Enjoy complimentary customisation on priority with our Enterprise License!
Market research analysts at Technavio have predicted that the global cell analysis market will grow steadily at a CAGR of around 7% by 2020. The increased need for accuracy and low cost will lead to the growth in demand for automated equipment in the market, which will be one of the major growth drivers for this industry. Automated cell counters normally use optical light scattering and changes in the electrical current. Continuous technological advancements employed in automated hematology instruments have enabled the enumeration and evaluation of blood cells with greater precisions. Since automated cell counters eliminate the need for reagents or dyes, the process also becomes more cost-effective. Manufacturers are also focusing on developing user-friendly cell analyzers that do not require manual calibration or maintenance. For instance, one of the prominent vendors EKF Diagnostics has already introduced the next-generation Hemo Control POC hemoglobin analyzer, which upgrades data management functionalities and can also store the results of almost 4,000 patients.
Due to the focus on reducing their manufacturing and distribution costs, several pharmaceutical and biotechnology companies have started outsourcing their drug discovery and research activities to (contract research organizations) CROs and research institutes, as these organizations use the latest technologies and high-end instruments for product development and clinical trials. This enables the source companies to focus more on the development of pricing and marketing strategies. This change in the vendor’s focus towards pricing market marketing strategies will subsequently increase the number of organizations collaborating with CROs and will be one of the major trends gaining traction in the market in the coming years.
The market is characterized by the presence of several large, medium-sized, and small manufacturers that provide diagnostic products and appears to be highly fragmented. The growth of the vendors depends on several factors such as market conditions, government support, and industry development. Players in the market also have the need to expand their geographical presence and also revive the domestic demand to achieve sustained growth over time. Vendors usually compete on the basis of product pricing, availability, brand, and variety. The local vendors offer cell analyzers at a comparatively lower price and pose a threat to big businesses in the market. Vendor competition in the market is intense, and the market is also expected to witness a number of vendors forming strategic partnerships to retain their share of the market.
The leading vendors in the market are -
The other prominent vendors in the market are Abcam, AccuBioTech, Agilent Technologies, ChemoMetec, Covance, EKF Diagnostic, ERBA Mannheim, Horiba Scientific, Icon, Illumina, Logos Biosystem, Mindray, Olympus Life Science Solutions, PerkinElmer, Quintiles, SFRI, Sigma-Aldrich, Sysmex Corporation, and Worthington Biochemical.
Accounting for a total market share of almost 58%, the consumables segment dominated the cell analysis market during 2015. This is mainly attributed to the repeated purchase of reagents and other consumables by various end-users to conduct tests. Consumables such as reagents, assay kits, and microplates will gain significance in live cell analysis due to the growing preference for in-vitro diagnostics (IVD), academics, drug discovery, agri-genomics, and personalized medicine. As a result, this market segment will continue to dominate the industry throughout the predicted period.
This market study estimates that in terms of geography, the Americas will account for more than 42% of the global cell analysis market by 2020 and will also dominate this market throughout the forecast period. The growth in research and developments in the field of regenerative medicine in Canada and the US will be one of the major factors that will bolster the growth of the cell analyzers market in this region. Additionally, the rise in funding for the National Institute of Health and the Biomedical Advanced Research and Development Authority will also fuel this market’s growth.
Technavio also offers customization on reports based on specific client requirement.
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Market landscape
PART 06: Product segmentation
PART 07: Geographical segmentation
PART 08: Market drivers
PART 09: Impact of drivers
PART 10: Market challenges
PART 11: Impact of drivers and challenges
PART 12: Market trends
PART 13: Vendor landscape
PART 14: Key vendor analysis
PART 15: Appendix
PART 16: Explore Technavio
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.